Anthony Sun
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anthony Sun
Earlier roles on record: CEO and Board Member at Zentalis Pharmaceuticals, Inc. (ZNTL) until May 10, 2022. The proxy statement of Zentalis Pharmaceuticals, Inc. reports total compensation of $9,098,448 for Anthony Sun in fiscal 2022, including a base salary of $245,511. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2014-01-01–2022-05-10
-
Start not stated–2022-05-10
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Former President and Chief Executive Officer | $245,511 | $9,098,448 |
| 2021 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Former President and Chief Executive Officer | $585,243 | $5,935,085 |
| 2020 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Former President and Chief Executive Officer | $561,232 | $15,044,399 |
| 2019 | Zentalis Pharmaceuticals, Inc. (ZNTL) | President and Chief Executive Officer | $455,091 | $1,577,882 |
Recent activity
No call appearances or filed executive changes recorded yet.